172 related articles for article (PubMed ID: 24920276)
21. MiR-320a inhibits malignant phenotype of melanoma cells via targeting PBX3.
Fu G; Lu J; Zheng Y; Wang P; Shen Q
J BUON; 2020; 25(4):2071-2077. PubMed ID: 33099955
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
Li R; Zhang L; Jia L; Duan Y; Li Y; Wang J; Bao L; Sha N
PLoS One; 2014; 9(4):e94855. PubMed ID: 24722758
[TBL] [Abstract][Full Text] [Related]
23. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF
BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391
[TBL] [Abstract][Full Text] [Related]
25. miR-137 inhibits proliferation of melanoma cells by targeting PAK2.
Hao S; Luo C; Abukiwan A; Wang G; He J; Huang L; Weber CE; Lv N; Xiao X; Eichmüller SB; He D
Exp Dermatol; 2015 Dec; 24(12):947-52. PubMed ID: 26186482
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
Dong F; Lou D
Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
[TBL] [Abstract][Full Text] [Related]
27. A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.
Poell JB; van Haastert RJ; de Gunst T; Schultz IJ; Gommans WM; Verheul M; Cerisoli F; van Puijenbroek AAFL; van Noort PI; Prevost GP; Schaapveld RQ; Cuppen E
PLoS One; 2012; 7(8):e43569. PubMed ID: 22927992
[TBL] [Abstract][Full Text] [Related]
28. A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion.
Babapoor S; Fleming E; Wu R; Dadras SS
PLoS One; 2014; 9(9):e107502. PubMed ID: 25237911
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of miR-1280 in melanoma by regulation of Src.
Sun V; Zhou WB; Nosrati M; Majid S; Thummala S; de Semir D; Bezrookove V; de Feraudy S; Chun L; Schadendorf D; Debs R; Kashani-Sabet M; Dar AA
Mol Ther; 2015 Jan; 23(1):71-8. PubMed ID: 25195599
[TBL] [Abstract][Full Text] [Related]
30. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
Kim JH; Ahn JH; Lee M
Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
34. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
Sun YW; Li XH; Wang H; Wu J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
[TBL] [Abstract][Full Text] [Related]
35. Hypoxic miRNAs expression are different between primary and metastatic melanoma cells.
Hino Y; Rahman MM; Lai YC; Husna AA; Chen HW; Hasan MN; Nakagawa T; Miura N
Gene; 2021 May; 782():145552. PubMed ID: 33705812
[TBL] [Abstract][Full Text] [Related]
36. ADAR1-mediated regulation of melanoma invasion.
Nemlich Y; Baruch EN; Besser MJ; Shoshan E; Bar-Eli M; Anafi L; Barshack I; Schachter J; Ortenberg R; Markel G
Nat Commun; 2018 May; 9(1):2154. PubMed ID: 29855470
[TBL] [Abstract][Full Text] [Related]
37. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
38. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
[TBL] [Abstract][Full Text] [Related]
39. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
Zhang K; Guo L
Gene; 2018 Jan; 641():272-278. PubMed ID: 29054757
[TBL] [Abstract][Full Text] [Related]
40. Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.
Das S; De S; Sengupta S
Mol Biol Rep; 2021 Mar; 48(3):2315-2324. PubMed ID: 33788053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]